The Role of the Gut Microbiome in the Development of Acute Pancreatitis
Related Experiment Video
Updated: Jul 5, 2025
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Ruilin Zhou1, Qingyang Wu2, Zihan Yang1
1Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Abstract:
With the explosion research on the gut microbiome in the recent years, much insight has been accumulated in comprehending the crosstalk between the gut microbiota community and host health. Acute pancreatitis (AP) is one of the gastrointestinal diseases associated with significant morbidity and subsequent mortality. Studies have elucidated that gut microbiota are engaged in the pathological process of AP. Herein, we summarize the major roles of the gut microbiome in the development of AP. We then portray the association between dysbiosis of the gut microbiota and the severity of AP. Finally, we illustrate the promises and challenges that arise when seeking to incorporate the microbiome in acute pancreatitis treatment.
Insights
The gut microbiome plays a key role in acute pancreatitis (AP) development and severity. Understanding this gut microbiota link offers potential new treatments for AP, though challenges remain.
Area of Science:
- Gastroenterology and Microbiology
- Host-Microbiome Interactions
Background:
- Recent research highlights the gut microbiome's influence on host health.
- Acute pancreatitis (AP) is a severe gastrointestinal disease with high mortality.
- Gut microbiota are implicated in the pathological mechanisms of AP.
Purpose of the Study:
- To summarize the gut microbiome's roles in AP development.
- To examine the link between gut dysbiosis and AP severity.
- To discuss the potential of microbiome-targeted therapies for AP.
Main Methods:
- Literature review and synthesis of current research on gut microbiome and AP.
- Analysis of studies investigating the association between microbial community structure and AP outcomes.
- Exploration of therapeutic strategies targeting the gut microbiome for AP management.
Main Results:
- The gut microbiome significantly contributes to the initiation and progression of AP.
- Gut dysbiosis correlates with increased AP severity and poorer patient outcomes.
- Modulating the gut microbiota shows promise as a therapeutic avenue for AP.
Conclusions:
- The gut microbiome is a critical factor in AP pathogenesis.
- Targeting gut dysbiosis may offer novel treatment strategies for acute pancreatitis.
- Further research is needed to overcome challenges in microbiome-based AP therapies.
Related Concept Videos
01:27Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...